2122 N. Craycroft Road
Suite #112
Tucson, AZ 85712
520-751-0100
irw@immuneclinic.com

Article Search

Latest News | Wellness Center | Functional Medicine | Conditions

Tumeric and Breast Cancer

Immune Recovery Clinic > Articles By Well Known and Acclaimed Medical Professionals > Cancer and Treatments > Tumeric and Breast Cancer
Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line.

Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ.

Department of Pathology, Miami Children's Hospital, 3100 SW 62nd Avenue, FL 33155, USA. cheppail.ramachandran@mch.com

The inhibitory effect of curcumin, the yellow-colored pigment from turmeric, on telomerase activity was analyzed in human mammary epithelial (MCF-10A) and breast cancer (MCF-7) cells. Telomerase activity in MCF-7 cells is 6.9-fold higher than that of human mammary epithelial cells. In MCF-7 cells, telomerase activity decreased with increasing concentrations of curcumin, inhibiting about 93.4% activity at 100 microM concentration. The inhibition of telomerase activity in MCF-7 cells may be due to down-regulation of hTERT expression. Increasing concentrations of curcumin caused a steady decrease in the level of hTERT mRNA in MCF-7 cells whereas the level of hTER and c-myc mRNAs remained the same. Our results suggest that curcumin inhibits telomerase activity by down-regulating hTERT expression in breast cancer cells and this down-regulation is not through the c-myc pathway.

PMID: 12104041 [PubMed - indexed for MEDLINE]